Cabaletta Bio, Inc. · NASDAQ:CABA
Bain Capital Life Sciences Opportunities III, LP reported a 9.57% stake in Cabaletta Bio, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Bain Capital Life Sciences Opportunities III, LP reported a 9.57% stake in Cabaletta Bio, Inc., 21,209,188 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 9.57%
- Shares
- 21,209,188
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP | 9.57% | 21,209,188 |
Source
Download original · View original at SEC
Related
- Cabaletta Bio, Inc.
- Bain Capital Life Sciences Opportunities III, LP
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Nov 16, 2026
- Schedule 13G/A · Norges Bank · Nov 12, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Oct 30, 2026